Hyperimmune immunoglobulin for people with COVID‐19

Valk, Sarah J.; Chai, Khai Li, Piechotta, Vanessa, Monsef, Ina, Wood, Erica M.; Lamikanra, Abigail A.; Roberts, David J.; McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J.; Skoetz, Nicole

Valk, Sarah J.; Chai, Khai Li, Piechotta, Vanessa, Monsef, Ina, Wood, Erica M.; Lamikanra, Abigail A.; Roberts, David J.; McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J.; Skoetz, Nicole.

The Cochrane database of systematic reviews ; 2021(10), 2021.

Article in English | EuropePMC | ID: covidwho-2058590

ABSTRACT

ABSTRACT

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID‐19; and to maintain the currency of the evidence.

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Language: English Journal: The Cochrane database of systematic reviews Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML